STSA

Satsuma Pharmaceuticals, Inc. Common Stock

Delisted

STSA was delisted on the 7th of June, 2023.

45 hedge funds and large institutions have $108M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-15
Holders Change %
-25%
% of All Funds
0.79%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
15
Reduced
17
Closed
19
Calls
$87K
Puts
$259K
Net Calls
-$172K
Net Calls Change
+$18K
Name Holding Trade Value Shares
Change
Shares
Change %
Deutsche Bank
51
Deutsche Bank
Germany
-$147K -20,840 Closed
B
52
Bailard
California
-$145K -20,500 Closed
First Trust Advisors
53
First Trust Advisors
Illinois
-$141K -20,012 Closed
Jane Street
54
Jane Street
New York
-$136K -19,257 Closed
JF
55
Jump Financial
Illinois
-$132K -18,700 Closed
PPA
56
Parametric Portfolio Associates
Washington
-$119K -16,921 Closed
WG
57
Winton Group
United Kingdom
-$98K -13,955 Closed
ECM
58
ExodusPoint Capital Management
New York
-$95K -13,474 Closed
UBS Group
59
UBS Group
Switzerland
-$21K -3,005 Closed
Bank of America
60
Bank of America
North Carolina
-$13K -1,903 Closed
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
-$13K -1,774 Closed
CAPTRUST Financial Advisors
62
CAPTRUST Financial Advisors
North Carolina
-$1K -128 Closed